SUMMARY A cord blood screening programme initiated in June 1973 had screened 68 000 normal deliveries by February 1979 with the detection of 216 cases of homozygous sickle cell disease. Regular review of these children in the Medical Research Council paediatric clinic has identified acute splenic sequestration as a major cause of morbidity and mortality in the first 5 years of life. In addition to classical episodes characterised by peripheral circulatory failure, minor episodes of increasing anaemia associated with an enlarging spleen and an active marrow were also common. These minor episodes appeared to have predictive value in children who later developed severe life-threatening episodes of acute splenic sequestration. Sustained hypersplenism was also appreciably more common in children developing minor or major episodes of acute splenic sequestration compared with those without such a history. It is proposed that the classification of acute splenic sequestration be expanded to include these minor episodes, and that consideration be given to prevention of recurrences by splenectomy particularly in patients who also develop sustained hypersplenism.
A prospective cohort study of 216 children with homozygous sickle cell (SS) disease followed since birth has identified acute splenic sequestration (ASS) as a major cause of morbidity and mortality in the first 5 years of life.' In addition to these 'classical' life-threatening attacks, minor episodes associated with less striking haematological and clinical changes have often been recognised. These minor episodes form a continuous spectrum with the 'classical' attacks and may precede and possibly be of predictive value for later more severe episodes of ASS. They may also presage the development of hypersplenism. In view of this it is proposed that the concept of ASS be expanded to include these minor episodes.
A minimal definition is required for these minor episodes and in this study we have investigated them using an arbitrary minimal definition of a fall in haemoglobin concentration of at least 2 g/dl, associated with evidence of marrow activity and an acutely enlarging spleen. The with further episodes of ASS, and one with pneumococcal septicaemia. As might be expected, episodes of ASS superimposed on hypersplenism carried a poor prognosis, death occurring in both episodes documented in the present study (Cases 9 and 10). Outcome. The outcome of episodes of ASS indicated a 12% mortality in the first episode. Recurrent episodes were common, 14 patients experiencing two episodes and 5 patients three episodes with mortality rates of 21 % and 20 % respectively (Fig. 2) . Of the 4 children surviving three episodes of ASS, 3 have had impalpable spleens for at least one year at ages 55, 62, and 66 months, and 1 child of 21 months has been a persistent defaulter. Mean interval between episodes was 6 months (range 2-17) and no difference in interval was apparent in the 4 recurrent cases with a fatal outcome. The possible prognostic value of mild episodes of ASS was illustrated by the case of a 4-year-old child, admitted to hospital with a 6-hour history of severe back pain, who was found to be in shock with a greatly enlarged spleen palpable to the right iliac fossa. The Hb was 2 5 g/dl and reticulocytes 38 %, and he died before transfusion could be instituted. This child had been regularly followed since birth and subsequent review of his haematological and clinical data showed two previous episodes of ASS (Fig. 3 ). The haemoglobin level had fallen by 4 7 g/dl in the first and by 3 -9 g/dl in the second, yet during the first episode he had been totally asymptomatic and during the second he had had a simple upper respiratory tract infection. It might be argued that expanding the definition to include all episodes a.sociated with haemoglobin falls of at least 2 g/dl will have included many mild and clinically insignificant events and will have detracted from the clinical usefulness of the definition. However, the high incidence of recurrence and the frequent development of hypersplenism suggest that the minor episodes are an indication for close supervision of these children.
Classical attacks of acute splenic sequestration constitute one of the most common causes of death among young children with SS disease in Jamaica.1
Of 25 deaths in the cohort study so far, the major cause has been acute splenic sequestration in 10 (40%) and 6 Provision of a regular supply of compatible blood, increasing difficulty in adequate matching, transfusion reactions from white cell and platelet antibodies, and risk of hepatitis are problems with chronic transfusion. There is also uncertainty about the most appropriate level of haemoglobin A to maintain and the duration of the overall programme. In addition, the development of iron overload may be a complication of chronic transfusions.
Surgical removal of the spleen undoubtedly abolishes the risk of further episodes of ASS but reluctance to perform splenectomy has been based on the avoidance of an 'unnecessary' operation in a condition likely to proceed to spontaneous splenic atrophy, the desire to retain any residual splenic immune function, and on an assessment of surgical and anaesthetic risks. Elective splenectomy however with modern anaesthetic and surgical techniques appears to be a safe and fairly minor procedure and it would appear therefore that the arguments against splenectomy in these children are less convincing.
The role of bacterial infection in the pathogenesis of ASS is difficult to define on the evidence presented here. The low yield from the 23 blood cultures suggests that bacterial infection is not an important precipitant of ASS, although viral infection, for which we have as yet no evidence, may be more significant. The post-mortem blood culture is difficult to interpret, since in 3 of these the cardiac clot culture was taken several hours after death and may therefore reflect post-mortem bacterial colonisation of the blood. In Cases 1 and 8 however, the blood cultures were taken within minutes of death. In any event children with ASS who have symptoms and signs of infection, however trivial, would normally receive treatment with antibiotics.
Chronic transfusion therapy and splenectomy are applicable only to patients surviving the first episode of ASS. To avoid the mortality in the first episode, attention must be directed to a search for prognostic haematological or clinical factors which determine the first episode. In the meantime we would suggest that any child with a history of one classical episode of ASS, or a minor episode followed by the development of sustained hypersplenism, should undergo splenectomy. In addition all children who have had one episode of ASS, according to our definition, should be very closely observed until splenic involution occurs.
